From Bio Co.,Ltd (KOSDAQ:377220)
South Korea · Delayed Price · Currency is KRW 1,873.00
-77.00 (-3.95%)
At close: Oct 8, 2026
From Bio Co.,Ltd Revenue
From Bio Co.,Ltd had revenue of 14.66B KRW in the quarter ending June 30, 2026, a decrease of -7.52%. This brings the company's revenue in the last twelve months to 71.64B, up 8.25% year-over-year. In the year 2025, From Bio Co.,Ltd had annual revenue of 72.16B with 7.41% growth. That makes From Bio Co.,Ltd the 27,460th largest company in the world by revenue and 1,661st in South Korea.
Revenue (ttm)
71.64B
Revenue Growth
+8.25%
P/S Ratio
0.15
Revenue / Employee
530.66M
Employees
140
Market Cap
10.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.16B | 4.98B | 7.41% |
| Dec 31, 2024 | 67.18B | 457.90M | 0.69% |
| Dec 31, 2023 | 66.72B | -32.61B | -32.83% |
| Dec 31, 2022 | 99.33B | -35.77B | -26.48% |
| Dec 31, 2021 | 135.10B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.